The results from this study provide a first glimpse into new developments emerging both during and in response to the pandemic, and which could have important implications for the future (EMCDDA)
Bibliography: Interventions – Treatment
HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine (SAMHSA)
Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019
This report describes 3 distinct client cohorts based on their patterns of treatment service use between 1 July 2014 and 30 June 2019. Clients who received intensive treatment were more likely than other cohorts to report receiving treatment for multiple principal drugs of concern and for more main treatment types across episodes (AIHW)
Examination of the links between parental conflict and substance misuse and the impacts on children’s outcomes
This report is a literature review examining the links between parental conflict and substance misuse and the impacts on children’s outcomes (UK Government)
Evidence review of drug treatment services for people who are homeless and use drugs
Evidence review of drug treatment services for people who are homeless and use drugs. Dublin: (Health Research Board)
Medication Assisted Treatment
MAT Standards for Scotland (Scottish Drugs Death Taskforce)
College publishes report on drug-related deaths in Scotland
The Royal College of Physicians of Edinburgh (“the College”) has launched a new report on drug-related deaths in Scotland, based on the views of leading experts
Maximising access to drug treatment while minimising diversion of medications
A new EMCDDA report looks at striking the balance
Participation and involvement of drug users in health services and policy making
This paper identifies the facilitators and barriers, which contribute to or jeopardise the process of drug users participation (European Harm Reduction Network)
UK government Drug Recovery Champion annual report
The first annual report from the UK Recovery Champion outlines the work he has undertaken since his appointment and sets out his future work programme (Home Office)
Treatment for drug addiction – how do patients cope in lockdown?
There are encouraging signs that people in treatment for drug addiction can manage their medication when they are entrusted with a substantial quantity of opiate substitutes and told to take it in small daily doses, finds a new ‘early insight’ report from researchers at the Universities of Bristol and Bath
Adult substance misuse treatment statistics 2019 to 2020: report
The number of people in treatment for opiate use was similar to the previous year (going up slightly from 139,845 to 140,599). Over half (52%) the adults in treatment were there for problems with opiates, and this remains the largest substance group (PHE)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews effective programs and practices to prevent HIV and increase adherence to and retention in care (SAMHSA)
EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region
The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new EMCDDA report: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both (Public Health England)
The National Survey on Drug Use and Health: 2019 (PDF)
NSDUH is a comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States (SAMHSA)
Does it matter where you get medication for opioid use disorder? A comparison of three types of clinics
Do substance-related outcomes vary across different types of community clinics? (Recovery Research Institute)
Substance use disorder recovery – there’s an app for that… but who uses it and who benefits?
To begin to address this gap in the clinical literature, the authors conducted an analysis of Sober Grid, a popular substance use disorder (SUD) recovery smartphone application (Recovery Research Institute)
Managing drug and alcohol misuse at work
Our report, written with input from charities and experts in the space, examines the management and prevention of drug and alcohol misuse at work (CIPD)
- 1
- 2
- 3
- …
- 13
- Next Page »
